Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE)

Exclusion Criteria

• •Currently enrolled in another clinical trial that might interfere with data collection.
• •Subject is pregnant or planning to become pregnant during the study
• •Active Implantable Medical Device, e.g. cardiac implantable electronic devices, bladder stimulators, diaphragm stimulators, implantable neuro stimulator, implantable active monitoring devices, implantable active drug administration devices, etc.
• •Have a prosthetic cardiac valve or previously underwent cardiac valve surgery.
• •Known allergy to materials used in the study (adhesive, ECG electrodes)
• •Diagnosed with syncope due to cardiologic causes.
• •Have had a myocardial infarction in the previous 90 days
• •Have been diagnosed with tachycardia that requires current medical treatment
• •Have any contraindications for exercise testing, tilt table test, Valsalva maneuver test or deep breathing test (judged by the study Principal Investigator)